Analysis
Put to the test: use of rapid testing technologies for covid-19
BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n208 (Published 03 February 2021) Cite this as: BMJ 2021;372:n208Linked Feature
Covid-19: How the UK is using lateral flow tests in the pandemic
Read our latest coverage of the coronavirus outbreak
Data supplement
Web extra
- Data Supplement - Appendix: analysis of covid-19 assays, challenges of mass asymptomatic testing, and main testing strategies
Related articles
- Practice Published: 23 October 2020; BMJ 371 doi:10.1136/bmj.m3862
- Editor's Choice Published: 04 February 2021; BMJ 372 doi:10.1136/bmj.n313
- Feature Published: 04 February 2021; BMJ 372 doi:10.1136/bmj.n287
- Practice Published: 22 June 2021; BMJ 373 doi:10.1136/bmj.n1411
- Analysis Published: 01 July 2021; BMJ 374 doi:10.1136/bmj.n1625
- Research Published: 07 July 2021; BMJ 374 doi:10.1136/bmj.n1637
- Editorial Published: 07 July 2021; BMJ 374 doi:10.1136/bmj.n1733
- Research Published: 23 February 2022; BMJ 376 doi:10.1136/bmj-2021-066871
- Research Published: 23 November 2022; BMJ 379 doi:10.1136/bmj-2022-071374
- Research Published: 23 November 2022; BMJ 379 doi:10.1136/bmj.o2712
See more
- Biden establishes top level office to reduce gun violence “to send a clear message to the country”BMJ September 25, 2023, 382 p2209; DOI: https://doi.org/10.1136/bmj.p2209
- How mobile clinics are helping those affected by Canada’s wildfiresBMJ September 25, 2023, 382 p2007; DOI: https://doi.org/10.1136/bmj.p2007
- Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trialBMJ September 25, 2023, 382 p2193; DOI: https://doi.org/10.1136/bmj.p2193
- Stephen Derek QuinnBMJ September 22, 2023, 382 p2168; DOI: https://doi.org/10.1136/bmj.p2168
- Don’t put up and shut like we did, say Welsh medical leaders about sexual harassmentBMJ September 22, 2023, 382 p2203; DOI: https://doi.org/10.1136/bmj.p2203
Cited by...
- Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: A systematic review and meta-analysis
- Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation
- Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2
- Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study
- Asymptomatic rapid testing for SARS-CoV-2
- Interpreting a lateral flow SARS-CoV-2 antigen test
- Could expanding the covid-19 case definition improve the UKs pandemic response?
- The accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis
- Covid-19: How the UK is using lateral flow tests in the pandemic
- Tests de detection rapides dantigenes pour le SRAS-CoV-2
- Le depistage des personnes asymptomatiques au moyen de tests antigeniques rapides: un outil de sante publique pour lutter contre la COVID-19
- Strategies for antigen testing: An alternative approach to widespread PCR testing
- Rapid antigen tests for SARS-CoV-2
- Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19
- Recalibrating SARS-CoV-2 antigen rapid lateral flow test relative sensitivity from validation studies to absolute sensitivity for detecting individuals with live virus
- Negative SARS-CoV-2 PCR or rapid antigen test result and the subsequent risk of being infectious: a mathematical simulation study
- Covid-19: Five steps to escape the cycle of lockdowns